Literature DB >> 29956408

Deregulation of the Notch pathway as a common road in viral carcinogenesis.

Elenaé Vázquez-Ulloa1,2, Marcela Lizano3, Marika Sjöqvist4, Leslie Olmedo-Nieva1, Adriana Contreras-Paredes3.   

Abstract

The Notch pathway is a conserved signaling pathway and a form of direct cell-cell communication related to many biological processes during development and adulthood. Deregulation of the Notch pathway is involved in many diseases, including cancer. Almost 20% of all cancer cases have an infectious etiology, with viruses responsible for at least 1.5 million new cancer cases per year. Seven groups of viruses have been classified as oncogenic: hepatitis B and C viruses (HBV and HCV respectively), Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV), human T lymphotropic virus (HTLV-1), human papillomavirus (HPV), and Merkel cell polyomavirus (MCPyV). These viruses share the ability to manipulate a variety of cell pathways that are critical in proliferation and differentiation, leading to malignant transformation. Viral proteins interact directly or indirectly with different members of the Notch pathway, altering their normal function. This review focuses exclusively on the direct interactions of viral oncoproteins with Notch elements, providing a deeper understanding of the dual behavior of the Notch pathway as activator or suppressor of neoplasia in virus-related cancers.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  EBV; HBV; HCV; HPV; HTLV-1; KSHV; MCPyV; NOTCH; cancer

Mesh:

Substances:

Year:  2018        PMID: 29956408     DOI: 10.1002/rmv.1988

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  8 in total

Review 1.  Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis.

Authors:  Trinath Das; Rong Zhong; Michael T Spiotto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways.

Authors:  Ugo Moens; Andrew Macdonald
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

Review 3.  Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.

Authors:  Masoumeh Farahani; Zahra Niknam; Leila Mohammadi Amirabad; Nasrin Amiri-Dashatan; Mehdi Koushki; Mohadeseh Nemati; Fahima Danesh Pouya; Mostafa Rezaei-Tavirani; Yousef Rasmi; Lobat Tayebi
Journal:  Biomed Pharmacother       Date:  2021-11-12       Impact factor: 7.419

4.  An enhanced triple fluorescence flow-cytometry-based assay shows differential activation of the Notch signaling pathway by human papillomavirus E6 proteins.

Authors:  JiaWen Lim; Elke Straub; Frank Stubenrauch; Thomas Iftner; Michael Schindler; Claudia Simon
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

Review 5.  Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.

Authors:  J Omar Muñoz-Bello; Adela Carrillo-García; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

6.  TMT-based quantitative proteomics analysis reveals the role of Notch signaling in FAdV-4-infected LMH cell.

Authors:  Yujuan Niu; Zhiyang Liu; Mengyu Wang; Ke Du; Kaihui Chang; Yonghe Ding
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

7.  Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition.

Authors:  Yoshihiro Otani; Ji Young Yoo; Samantha Chao; Joseph Liu; Alena Cristina Jaime-Ramirez; Tae Jin Lee; Brian Hurwitz; Yuanqing Yan; Hongsheng Dai; Joseph C Glorioso; Michael A Caligiuri; Jianhua Yu; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2020-03-05       Impact factor: 12.531

8.  Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome.

Authors:  Jilani Purusottapatnam Shaik; Ibrahim O Alanazi; Akbar Ali Khan Pathan; Narasimha Reddy Parine; Majid A Almadi; Nahla A Azzam; Abdulrahman M Aljebreen; Othman Alharbi; Mohammad Saud Alanazi; Zahid Khan
Journal:  J Oncol       Date:  2020-03-09       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.